Cohance Lifesciences Limited (BOM:543064)

Cohance Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 18, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	361,182	293,004	172,366	120,256	157,436	126,468
Market Cap Growth	69.99%	69.99%	43.33%	-23.61%	24.49%	394.20%
Enterprise Value	362,609	287,341	165,176	117,048	156,449	127,128
Last Close Price	944.05	1159.80	676.60	472.70	608.03	483.61
PE Ratio	134.83	109.38	57.40	29.24	34.69	34.90
PS Ratio	30.16	24.47	16.40	8.97	11.93	12.53
PB Ratio	19.62	15.92	8.40	6.93	10.31	10.71
P/TBV Ratio	36.95	29.97	8.67	7.19	10.32	10.73
P/FCF Ratio	272.69	221.22	56.20	70.21	61.79	46.55
P/OCF Ratio	125.34	101.68	48.08	26.30	47.71	33.06
EV/Sales Ratio	30.28	23.99	15.71	8.73	11.85	12.59
EV/EBITDA Ratio	96.64	76.58	40.65	20.44	27.00	28.85
EV/EBIT Ratio	121.80	96.52	46.59	22.25	28.89	31.02
EV/FCF Ratio	273.77	216.94	53.86	68.34	61.40	46.79
Debt / Equity Ratio	0.15	0.15	0.03	0.04	0.06	0.12
Debt / EBITDA Ratio	0.74	0.74	0.16	0.12	0.17	0.32
Debt / FCF Ratio	2.11	2.11	0.21	0.41	0.38	0.53
Asset Turnover	0.45	0.45	0.50	0.71	0.80	0.76
Inventory Turnover	1.53	1.53	1.60	1.87	2.24	2.19
Quick Ratio	1.57	1.57	9.46	4.17	3.85	1.56
Current Ratio	2.43	2.43	11.82	6.37	5.36	2.57
Return on Equity (ROE)	13.61%	13.61%	15.86%	25.21%	33.52%	35.78%
Return on Assets (ROA)	7.04%	7.04%	10.50%	17.33%	20.49%	19.35%
Return on Capital (ROIC)	8.79%	8.79%	11.30%	19.18%	22.96%	21.76%
Return on Capital Employed (ROCE)	11.20%	11.20%	16.50%	29.10%	33.40%	32.70%
Earnings Yield	0.74%	0.91%	1.74%	3.42%	2.88%	2.86%
FCF Yield	0.37%	0.45%	1.78%	1.42%	1.62%	2.15%
Dividend Yield	-	-	-	-	0.33%	0.41%
Payout Ratio	-	-	-	49.52%	11.22%	7.03%
Buyback Yield / Dilution	-0.69%	-0.69%	-	-	-	0.00%
Total Shareholder Return	-	-0.69%	-	-	0.33%	0.41%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.